Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01015_DB01124_nanopub.RA6BFYWbdvHUAKV3gu4BYgfDTywUC5mUbeSlAh7LfzsuA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01015_DB01124 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01015_DB01124 label "DDI between Sulfamethoxazole and Tolbutamide - Tolbutamide, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Sulfamethoxazole. Consider alternate therapy or monitor for changes in Sulfamethoxazole therapeutic and adverse effects if Tolbutamide is initiated, discontinued or dose changed. [drugbank_resource:DB01015_DB01124]" assertion.
- drugbank_resource:DB01015_DB01124 identifier "drugbank_resource:DB01015_DB01124" assertion.
- drugbank_resource:DB01015_DB01124 title "DDI between Sulfamethoxazole and Tolbutamide - Tolbutamide, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Sulfamethoxazole. Consider alternate therapy or monitor for changes in Sulfamethoxazole therapeutic and adverse effects if Tolbutamide is initiated, discontinued or dose changed." assertion.
- drugbank:DB01124 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01015_DB01124 assertion.
- drugbank:DB01015 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01015_DB01124 assertion.